dc.contributor.author |
Mehta, Suneela |
en |
dc.contributor.author |
Wells, Linda |
en |
dc.contributor.author |
Riddell, Tania |
en |
dc.contributor.author |
Kerr, Andrew |
en |
dc.contributor.author |
Pylypchuk, Romana |
en |
dc.contributor.author |
Marshall, Roger |
en |
dc.contributor.author |
Ameratunga, Shanthi |
en |
dc.contributor.author |
Chan, WC |
en |
dc.contributor.author |
Thornley, Simon |
en |
dc.contributor.author |
Crengle, Suzanne |
en |
dc.contributor.author |
Harrison, Jeffrey |
en |
dc.contributor.author |
Drury, P |
en |
dc.contributor.author |
Elley, Carolyn |
en |
dc.contributor.author |
Bell, F |
en |
dc.contributor.author |
Jackson, Rodney |
en |
dc.coverage.spatial |
New Zealand |
en |
dc.date.accessioned |
2012-03-29T23:07:14Z |
en |
dc.date.issued |
2011-06 |
en |
dc.identifier.citation |
Journal of Primary Health Care 3(2):93-101 Jun 2011 |
en |
dc.identifier.issn |
1172-6156 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/16142 |
en |
dc.description.abstract |
Blood pressure-lowering (BPL) and lipid-lowering (LL) medications together reduce estimated absolute five-year cardiovascular disease (CVD) risk by >40%. International studies indicate that the proportion of people with CVD receiving pharmacotherapy increases with advancing age. |
en |
dc.language |
eng |
en |
dc.publisher |
Royal New Zealand College of General Practitioners |
en |
dc.relation.ispartofseries |
Journal of Primary Health Care |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Adult |
en |
dc.subject |
Age Factors |
en |
dc.subject |
Aged |
en |
dc.subject |
Antihypertensive Agents |
en |
dc.subject |
Cardiovascular Diseases |
en |
dc.subject |
Decision Support Systems, Clinical |
en |
dc.subject |
Drug Utilization |
en |
dc.subject |
Female |
en |
dc.subject |
Health Services Accessibility |
en |
dc.subject |
Humans |
en |
dc.subject |
Hypolipidemic Agents |
en |
dc.subject |
Male |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
New Zealand |
en |
dc.subject |
Primary Health Care |
en |
dc.subject |
Risk Assessment |
en |
dc.title |
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15). |
en |
dc.type |
Journal Article |
en |
pubs.issue |
2 |
en |
pubs.begin-page |
93 |
en |
pubs.volume |
3 |
en |
dc.rights.holder |
Copyright: Royal New Zealand College of General Practitioners |
en |
dc.identifier.pmid |
21625656 |
en |
pubs.author-url |
http://www.rnzcgp.org.nz/jphc-june-2011/ |
en |
pubs.end-page |
101 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
210998 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Pharmacy |
en |
pubs.org-id |
Population Health |
en |
pubs.org-id |
Epidemiology & Biostatistics |
en |
pubs.org-id |
Gen.Practice& Primary Hlthcare |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Medicine Department |
en |
dc.identifier.eissn |
1172-6156 |
en |
pubs.record-created-at-source-date |
2012-02-21 |
en |
pubs.dimensions-id |
21625656 |
en |